Below are the most recent publications written about "Atrial Natriuretic Factor" by people in Profiles.
-
Kornej J, B?ttner P, Sommer P, Dagres N, Dinov B, Schumacher K, Bollmann A, Hindricks G. Prediction of electro-anatomical substrate using APPLE score and biomarkers. Europace. 2019 Jan 01; 21(1):54-59.
-
Seew?ster T, B?ttner P, Nedios S, Sommer P, Dagres N, Schumacher K, Bollmann A, Hilbert S, Jahnke C, Paetsch I, Hindricks G, Kornej J. Association Between Cardiovascular Magnetic Resonance-Derived Left Atrial Dimensions, Electroanatomical Substrate and NT-proANP Levels in Atrial Fibrillation. J Am Heart Assoc. 2018 10 02; 7(19):e009427.
-
B?ttner P, Schumacher K, Dinov B, Zeynalova S, Sommer P, Bollmann A, Husser D, Hindricks G, Kornej J. Role of NT-proANP and NT-proBNP in patients with atrial fibrillation: Association with atrial fibrillation progression phenotypes. Heart Rhythm. 2018 08; 15(8):1132-1137.
-
Alqahtani MF, Smith CM, Weiss SL, Dawson S, Ralay Ranaivo H, Wainwright MS. Evaluation of New Diagnostic Biomarkers in Pediatric Sepsis: Matrix Metalloproteinase-9, Tissue Inhibitor of Metalloproteinase-1, Mid-Regional Pro-Atrial Natriuretic Peptide, and Adipocyte Fatty-Acid Binding Protein. PLoS One. 2016; 11(4):e0153645.
-
Rajagopal K, Saha P, Mohammed I, Sanchez PG, Li T, Wu ZJ, Griffith BP. Effects of small platform catheter-based left ventricular assist device support on regional myocardial signal transduction. J Thorac Cardiovasc Surg. 2015 Nov; 150(5):1332-41.
-
Lee R, Xu B, Rame JE, Felkin LE, Barton P, Dries DL. Regulated inositol-requiring protein 1-dependent decay as a mechanism of corin RNA and protein deficiency in advanced human systolic heart failure. J Am Heart Assoc. 2014 Dec; 3(6):e001104.
-
Morita Y, Kohsaka S, Oshima K, Yoshikawa T, Fukuda K. Use of carperitide infusion for acutely decompensated heart failure. Crit Care. 2012 Jan 25; 16(1):406.
-
Rockwood DN, Akins RE, Parrag IC, Woodhouse KA, Rabolt JF. Culture on electrospun polyurethane scaffolds decreases atrial natriuretic peptide expression by cardiomyocytes in vitro. Biomaterials. 2008 Dec; 29(36):4783-91.
-
Silver MA, Maisel A, Yancy CW, McCullough PA, Burnett JC, Francis GS, Mehra MR, Peacock WF, Fonarow G, Gibler WB, Morrow DA, Hollander J. BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases. Congest Heart Fail. 2004 Sep-Oct; 10(5 Suppl 3):1-30.
-
Liao WC, Vesterqvist O, Delaney C, Jemal M, Ferreira I, Ford N, Swanson B, Uderman H. Pharmacokinetics and pharmacodynamics of the vasopeptidase inhibitor, omapatrilat in healthy subjects. Br J Clin Pharmacol. 2003 Oct; 56(4):395-406.